Correlation Between Orchestra BioMed and Telix Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Orchestra BioMed and Telix Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Orchestra BioMed and Telix Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Orchestra BioMed Holdings and Telix Pharmaceuticals Limited, you can compare the effects of market volatilities on Orchestra BioMed and Telix Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Orchestra BioMed with a short position of Telix Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Orchestra BioMed and Telix Pharmaceuticals.
Diversification Opportunities for Orchestra BioMed and Telix Pharmaceuticals
-0.04 | Correlation Coefficient |
Good diversification
The 3 months correlation between Orchestra and Telix is -0.04. Overlapping area represents the amount of risk that can be diversified away by holding Orchestra BioMed Holdings and Telix Pharmaceuticals Limited in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Telix Pharmaceuticals and Orchestra BioMed is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Orchestra BioMed Holdings are associated (or correlated) with Telix Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Telix Pharmaceuticals has no effect on the direction of Orchestra BioMed i.e., Orchestra BioMed and Telix Pharmaceuticals go up and down completely randomly.
Pair Corralation between Orchestra BioMed and Telix Pharmaceuticals
Given the investment horizon of 90 days Orchestra BioMed is expected to generate 2.11 times less return on investment than Telix Pharmaceuticals. In addition to that, Orchestra BioMed is 1.96 times more volatile than Telix Pharmaceuticals Limited. It trades about 0.05 of its total potential returns per unit of risk. Telix Pharmaceuticals Limited is currently generating about 0.22 per unit of volatility. If you would invest 1,452 in Telix Pharmaceuticals Limited on September 3, 2024 and sell it today you would earn a total of 184.00 from holding Telix Pharmaceuticals Limited or generate 12.67% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Orchestra BioMed Holdings vs. Telix Pharmaceuticals Limited
Performance |
| Timeline |
| Orchestra BioMed Holdings |
| Telix Pharmaceuticals |
Orchestra BioMed and Telix Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Orchestra BioMed and Telix Pharmaceuticals
The main advantage of trading using opposite Orchestra BioMed and Telix Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Orchestra BioMed position performs unexpectedly, Telix Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Telix Pharmaceuticals will offset losses from the drop in Telix Pharmaceuticals' long position.| Orchestra BioMed vs. Tandy Leather Factory | Orchestra BioMed vs. Westinghouse Air Brake | Orchestra BioMed vs. Citi Trends | Orchestra BioMed vs. Nike Inc |
| Telix Pharmaceuticals vs. Genscript Biotech | Telix Pharmaceuticals vs. Keros Therapeutics | Telix Pharmaceuticals vs. Zentalis Pharmaceuticals Llc | Telix Pharmaceuticals vs. Innovent Biologics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Other Complementary Tools
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |